Advertisement

Advertisement

AU:RAC Stock Latest News

Racura Oncology details strengthened corporate governance framework

Company AnnouncementsRacura Oncology details strengthened corporate governance framework

Race Oncology lodges ASX corporate governance statement for FY26

PremiumCompany Announcements

Race Oncology lodges ASX corporate governance statement for FY26

9h ago

Racura Oncology posts deeper annual loss but lifts net asset backing

PremiumCompany Announcements

Racura Oncology posts deeper annual loss but lifts net asset backing

9h ago

Racura Oncology CEO to Spotlight Phase 3 Cancer Programs at TechKnow Invest Conference

PremiumCompany Announcements

Racura Oncology CEO to Spotlight Phase 3 Cancer Programs at TechKnow Invest Conference

28d ago

Racura Advances HARNESS-1 Trial After Safe First-Patient Treatment With RC220 Combo

PremiumCompany Announcements

Racura Advances HARNESS-1 Trial After Safe First-Patient Treatment With RC220 Combo

28d ago

Race Oncology Options Expire, Slightly Tightening Capital Structure

PremiumCompany AnnouncementsRace Oncology Options Expire, Slightly Tightening Capital Structure

1M ago

Racura to Present RC220 Cardio-Oncology Phase 1 Data at 2026 Global Summit

Company Announcements

Racura to Present RC220 Cardio-Oncology Phase 1 Data at 2026 Global Summit

2M ago

Racura Oncology to Spotlight RC220 Pipeline at New Zealand Investor Events

Company Announcements

Racura Oncology to Spotlight RC220 Pipeline at New Zealand Investor Events

2M ago

Racura Oncology gains ethics approval to expand HARNESS-1 lung cancer trial

PremiumCompany Announcements

Racura Oncology gains ethics approval to expand HARNESS-1 lung cancer trial

2M ago

Race Oncology Options Expire Unexercised, Trimming Potential Dilution

PremiumCompany Announcements

Race Oncology Options Expire Unexercised, Trimming Potential Dilution

2M ago

Racura Oncology Begins Dosing in Phase 1 HARNESS-1 Lung Cancer Trial

PremiumCompany Announcements

Racura Oncology Begins Dosing in Phase 1 HARNESS-1 Lung Cancer Trial

2M ago

Racura Oncology Sets Investor Briefings in Perth and Auckland

PremiumCompany Announcements

Racura Oncology Sets Investor Briefings in Perth and Auckland

2M ago

Racura Oncology Raises $34.3m to Fully Fund RC220 Cancer Trials

PremiumCompany AnnouncementsRacura Oncology Raises $34.3m to Fully Fund RC220 Cancer Trials

2M ago

Racura Oncology Issues New Shares Under Option Underwriting to Support Clinical Pipeline

Company Announcements

Racura Oncology Issues New Shares Under Option Underwriting to Support Clinical Pipeline

2M ago

Racura Oncology Seeks ASX Quotation for Over 500,000 New Shares

Company Announcements

Racura Oncology Seeks ASX Quotation for Over 500,000 New Shares

2M ago

Racura Raises $24.4m as 97% of Piggyback Options Are Exercised

PremiumCompany Announcements

Racura Raises $24.4m as 97% of Piggyback Options Are Exercised

3M ago

Racura Oncology Options Lapse, Trimming Potential Equity Dilution

PremiumCompany Announcements

Racura Oncology Options Lapse, Trimming Potential Equity Dilution

3M ago

Racura Oncology Raises $31.2m as Specialist Investor Takes Strategic Stake

PremiumCompany Announcements

Racura Oncology Raises $31.2m as Specialist Investor Takes Strategic Stake

3M ago

Racura Oncology Seeks ASX Quotation for Additional Ordinary Shares

PremiumCompany Announcements

Racura Oncology Seeks ASX Quotation for Additional Ordinary Shares

3M ago

Racura Oncology Seeks ASX Quotation for Over 1.1 Million New Shares

PremiumCompany AnnouncementsRacura Oncology Seeks ASX Quotation for Over 1.1 Million New Shares

3M ago

Racura Oncology Plans Share Placement to Fund Oncology Programs

Company Announcements

Racura Oncology Plans Share Placement to Fund Oncology Programs

3M ago

Racura Oncology underwrites expiring options to secure $25m for cancer trials

Company Announcements

Racura Oncology underwrites expiring options to secure $25m for cancer trials

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >